Back

Incidence of death and thromboembolic events in patients with light chains and transthyretin cardiac amyloidosis: data from an institutional registry

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Predicting outcomes in cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Pilar Domenech

Hospital Italiano de Buenos Aires, Buenos Aires (Argentina)

6 More presentations in this session

Presentation thumbnail
Aortic calcium scoring from computed tomography for signal localization by bone scintigraphy to predict aortic stenosis and assess prognosis in patients with transthyretin cardiac amyloidosis
Mr B. Guillaume (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study
Doctor D. Laenens (Mechelen, BE)
Abstract Slides Video
Presentation thumbnail
Sex-based differences in phenotypic expression and prognosis of transthyretin cardiac amyloidosis associated with the Val122Ile variant
Doctor A. Monfort (Fort-de-France, MQ)
Abstract Slides Video
Presentation thumbnail
The incidence of death and risk factors for mortality in cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records
Doctor L. Anderson (London, GB)
Abstract Slides Video
Presentation thumbnail
Myocardial stiffness and mortality risk in cardiac amyloidosis: a shear wave elastography analysis
Doctor C. Espinoza Romero (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting outcomes in cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

30 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Trends in prevalence and clinical outcomes of patients with atrial fibrillation and cardiac amyloidosis- from a nationwide registry
thumbnail
Congress Presentation
Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.
thumbnail
Congress Session
Advances in amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources